NeoGenomics, Inc. Accrued Liabilities and Other Liabilities
NeoGenomics, Inc. (NEO) had Accrued Liabilities and Other Liabilities of $23.05 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-07-28
- 2026-06-30: Accrued Liabilities and Other Liabilities $23.05M.
- 2026-03-31: Accrued Liabilities and Other Liabilities $12.73M.
- 2025-12-31: Accrued Liabilities and Other Liabilities $11.97M; Accrued Liabilities and Other Liabilities as first filed $12.00M.
- 2025-09-30: Accrued Liabilities and Other Liabilities $17.39M.
| Period end | Accrued Liabilities and Other Liabilities | Accrued Liabilities and Other Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $23.05M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $12.73M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $11.97M 10-Q · filed 2026-07-28 | $12.00M 10-K · filed 2026-02-17 |
| 2025-09-30 | $17.39M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $18.48M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $18.63M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $12.62M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $23.00M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $17.27M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $18.13M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $15.07M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $18.68M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $18.17M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $17.96M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $15.07M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $20.42M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $16.07M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $16.57M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $17.80M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $18.09M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $25.30M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $14.02M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $11.65M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $8.68M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $7.91M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $8.97M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $7.55M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $7.90M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $7.89M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $18.33M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $8.99M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $7.52M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $9.89M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $9.88M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $6.14M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $5.00M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $3.19M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $2.77M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $4.25M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $4.38M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $7.60M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $4.98M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $7.37M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $1.33M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $1.23M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $1.24M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.21M 10-K · filed 2016-04-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |